Central core disease: clinical, pathological, and genetic features

Central core disease (CCD) is a dominantly inherited congenital myopathy allelic to malignant hyperthermia (MH) caused by mutations in the RYR1 gene on chromosome 19q13.1. Eleven individuals with RYR1 mutations are described. Four index cases showed features consistent with a congenital myopathy (hy...

Full description

Saved in:
Bibliographic Details
Published in:Archives of disease in childhood Vol. 88; no. 12; pp. 1051 - 1055
Main Authors: Quinlivan, R M, Muller, C R, Davis, M, Laing, N G, Evans, G A, Dwyer, J, Dove, J, Roberts, A P, Sewry, C A
Format: Journal Article
Language:English
Published: London BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health 01-12-2003
BMJ
BMJ Publishing Group Ltd
BMJ Publishing Group LTD
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Central core disease (CCD) is a dominantly inherited congenital myopathy allelic to malignant hyperthermia (MH) caused by mutations in the RYR1 gene on chromosome 19q13.1. Eleven individuals with RYR1 mutations are described. Four index cases showed features consistent with a congenital myopathy (hypotonia, delayed motor milestones, and skeletal abnormalities including congenital hip dislocation and scoliosis). All four cases and subsequently seven other family members were found to possess novel mutations in the RYR1 gene. The degree of disability varied from one clinically normal individual, to another who had never achieved independent ambulation (the only patient with a de novo mutation). Four cases showed a mild reduction in vital capacity, repeated nocturnal polysomnography showed hypoxaemia in one case. A variety of muscle biopsy features were found; central cores were absent in the youngest case, and the biopsy specimens from two others were more suggestive of mini-core myopathy. In all cases missense mutations in exons 101, 102, and 103 of the RYR1 gene on were found. Future laboratory diagnosis of suspected cases and family members will be less invasive and more accurate with DNA analysis. Clinicians, especially paediatricians and orthopaedic surgeons, should be aware of this disorder because of the potential risk of MH.
Bibliography:href:archdischild-88-1051.pdf
local:0881051
ark:/67375/NVC-30GRH8SX-4
Correspondence to:
 Dr R Quinlivan
 Neuromuscular Clinic, Children’s Unit, Robert Jones and Agnes Hunt NHS Trust, Oswestry SY10 7AG, UK; Rcmq37@aol.com
PMID:14670767
istex:6EC8F7C1C0DB9DBF4541FCFCE7DD800BFC938734
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0003-9888
1468-2044
DOI:10.1136/adc.88.12.1051